发明名称 Oral formulations and lipophilic salts of methylnal trexone
摘要 The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration.
申请公布号 US8956651(B2) 申请公布日期 2015.02.17
申请号 US201313966779 申请日期 2013.08.14
申请人 Wyeth, LLC 发明人 Shah Syed M.;Diorio Christopher Richard;Ehrnsperger Eric C.;Meng Xu;Al Shareffi Kadum A.;Cohen Jonathan Marc
分类号 A61K9/20;A61K31/485;C07D489/08;A61K9/28;A61K47/12;A61K47/20 主分类号 A61K9/20
代理机构 McCarter & English, LLP 代理人 McCarter & English, LLP ;Sparks Jonathan M.;Gulati Maneesh
主权项 1. A pharmaceutical composition for oral administration comprising a solid dosage of (i) methylnaltrexone, or a pharmaceutically acceptable salt thereof, and (ii) an amphiphilic pharmaceutically acceptable excipient, and wherein the composition comprises from about 7% to about 75% methylnaltrexone cation and an anion of the amphiphilic pharmaceutically acceptable excipient based upon the total weight of the composition and wherein the composition in solution has an apparent octanol/water partition coefficient for methylnaltrexone of at least 0.25 at a pH between 1 and 4.
地址 Madison NJ US